- Home
- CAPN vs OPTN Comparison
CAPN vs OPTN Comparison
Compare CAPN & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPN
- OPTN
- Stock Information
- Founded
- CAPN 2024
- OPTN 2010
- Country
- CAPN United States
- OPTN United States
- Employees
- CAPN N/A
- OPTN N/A
- Industry
- CAPN
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- CAPN
- OPTN Health Care
- Exchange
- CAPN NYSE
- OPTN Nasdaq
- Market Cap
- CAPN 78.3M
- OPTN 78.4M
- IPO Year
- CAPN 2024
- OPTN 2017
- Fundamental
- Price
- CAPN N/A
- OPTN $0.46
- Analyst Decision
- CAPN
- OPTN Strong Buy
- Analyst Count
- CAPN 0
- OPTN 3
- Target Price
- CAPN N/A
- OPTN $3.00
- AVG Volume (30 Days)
- CAPN 7.0
- OPTN 1.2M
- Earning Date
- CAPN 01-01-0001
- OPTN 11-12-2024
- Dividend Yield
- CAPN N/A
- OPTN N/A
- EPS Growth
- CAPN N/A
- OPTN N/A
- EPS
- CAPN N/A
- OPTN N/A
- Revenue
- CAPN N/A
- OPTN $75,672,000.00
- Revenue This Year
- CAPN N/A
- OPTN $13.42
- Revenue Next Year
- CAPN N/A
- OPTN $52.99
- P/E Ratio
- CAPN N/A
- OPTN N/A
- Revenue Growth
- CAPN N/A
- OPTN 5.13
- 52 Week Low
- CAPN $9.95
- OPTN $0.32
- 52 Week High
- CAPN $10.14
- OPTN $2.10
- Technical
- Relative Strength Index (RSI)
- CAPN N/A
- OPTN 39.55
- Support Level
- CAPN N/A
- OPTN $0.42
- Resistance Level
- CAPN N/A
- OPTN $0.57
- Average True Range (ATR)
- CAPN 0.00
- OPTN 0.05
- MACD
- CAPN 0.00
- OPTN 0.00
- Stochastic Oscillator
- CAPN 0.00
- OPTN 26.39
About CAPN CAYSON ACQUISITION CORP
Cayson Acquisition Corp is a blank check company.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.